Pseudomonas aeruginosa serotypes in nosocomial pneumonia: Prevalence and clinical outcomes

Critical Care

Volumn 18, Issue 1, 2014, Pages

  Lu, Qin ^a   Eggimann, Philippe ^b   Luyt, Charles Edouard ^a   Wolff, Michel ^c   Tamm, Michael ^d   François, Bruno ^e   Mercier, Emmanuelle ^f   Garbino, Jorge ^g   Laterre, Pierre François ^h   Koch, Holger ⁱ   Gafner, Verena ⁱ   Rudolf, Michael P ⁱ   Mus, Erkan ⁱ   Perez, Antonio ⁱ   Lazar, Hedvika ⁱ   Chastre, Jean ^a   Rouby, Jean Jacques ^a  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c BICHAT HOSPITAL   (France)

^d UNIVERSITY HOSPITAL BASEL   (Switzerland)

^e DUPUYTREN UNIVERSITY HOSPITAL   (France)

^f CHU BRETONNEAU   (France)

^g GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^h CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

ⁱ Kenta Biotech   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; BLOOD; CLINICAL TRIAL; COHORT ANALYSIS; CROSS INFECTION; FEMALE; HUMAN; ISOLATION AND PURIFICATION; MALE; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PNEUMONIA, BACTERIAL; PREVALENCE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADULT; AGED; COHORT STUDIES; CROSS INFECTION; FEMALE; HUMANS; MALE; MIDDLE AGED; PNEUMONIA, BACTERIAL; PREVALENCE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84894254047     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc13697     Document Type: Article

References (40)

1. Eggimann P, Pittet D. Infection control in the ICU. Chest 2001, 120:2059-2093. 10.1378/chest.120.6.2059, 11742943.
2. Fujitani S, Sun HY, Yu VL, Weingarten JA. Pneumonia due to Pseudomonas aeruginosa: part I: epidemiology, clinical diagnosis, and source. Chest 2011, 139:909-919. 10.1378/chest.10-0166, 21467058.
3. Crouch Brewer S, Wunderink RG, Jones CB, Leeper KV. Ventilator-associated pneumonia due to Pseudomonas aeruginosa. Chest 1996, 109:1019-1029. 10.1378/chest.109.4.1019, 8635325.
4. Fagon JY, Chastre J, Hance AJ, Montravers P, Novara A, Gibert C. Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am J Med 1993, 94:281-288. 10.1016/0002-9343(93)90060-3, 8452152.
5. Fagon JY, Chastre J, Domart Y, Trouillet JL, Pierre J, Darne C, Gibert C. Nosocomial pneumonia in patients receiving continuous mechanical ventilation. Prospective analysis of 52 episodes with use of a protected specimen brush and quantitative culture techniques. Am Rev Respir Dis 1989, 139:877-884. 10.1164/ajrccm/139.4.877, 2930067.
6. Meitert E, Petrescu AM, Butoianu A. Serotyping of Pseudomonas aeruginosa strains by slide coagglutination. Arch Roum Pathol Exp Microbiol 1990, 49:37-42.
7. Rocchetta HL, Burrows LL, Lam JS. Genetics of O-antigen biosynthesis in Pseudomonas aeruginosa. Microbiol Mol Biol Rev 1999, 63:523-553. 103745, 10477307.
8. Liu PV. Comparison of the Chinese schema and the International antigenic typing system for serotyping Pseudomonas aeruginosa. J Clin Microbiol 1987, 25:824-826. 266096, 3108310.
9. Liu PV, Wang S. Three new major somatic antigens of Pseudomonas aeruginosa. J Clin Microbiol 1990, 28:922-925. 267837, 2112563.
10. Estahbanati HK, Kashani PP, Ghanaatpisheh F. Frequency of Pseudomonas aeruginosa serotypes in burn wound infections and their resistance to antibiotics. Burns 2002, 28:340-348. 10.1016/S0305-4179(02)00024-4, 12052372.
11. Rodriguez DS, Rizo AG, Monroy SP, Reyes T. Antimicrobial susceptibility and serotyping of Pseudomonas aeruginosa isolated from HIV/AIDS patients. Rev Cubana Med Trop 2002, 54:142-146.
12. Faure K, Shimabukuro D, Ajayi T, Allmond LR, Sawa T, Wiener-Kronish JP. O-antigen serotypes and type III secretory toxins in clinical isolates of Pseudomonas aeruginosa. J Clin Microbiol 2003, 41:2158-2160. 10.1128/JCM.41.5.2158-2160.2003, 154700, 12734267.
13. Fonseca AP, Correia P, Extremina CI, Sousa JC, Tenreiro R, Barros H. Molecular epidemiology of Pseudomonas aeruginosa clinical isolates from Portuguese Central Hospital. Folia Microbiol (Praha) 2008, 53:540-546. 10.1007/s12223-008-0086-y, 19381482.
14. Hostacka A, Majtan V. Serotyping and virulence factors of Pseudomonas aeruginosa clinical isolates. Acta Microbiol Immunol Hung 1997, 44:141-146.
15. Le Berre R, Nguyen S, Nowak E, Kipnis E, Pierre M, Quenee L, Ader F, Lancel S, Courcol R, Guery BP, Faure K. Relative contribution of three main virulence factors in Pseudomonas aeruginosa pneumonia. Crit Care Med 2011, 39:2113-2120. 10.1097/CCM.0b013e31821e899f, 21572326.
16. Bert F, Lambert-Zechovsky N. Comparative distribution of resistance patterns and serotypes in Pseudomonas aeruginosa isolates from intensive care units and other wards. J Antimicrob Chemother 1996, 37:809-813. 10.1093/jac/37.4.809, 8722547.
17. Patzer J, Dzierzanowska D. The resistance patterns and serotypes of Pseudomonas aeruginosa strains isolated from children. J Antimicrob Chemother 1991, 28:869-875. 10.1093/jac/28.6.869, 1816183.
18. Jamasbi RJ, Proudfoot EM. Phenotypic and genotypic characteristics of clinical isolates of pseudomonas aeruginosa: rate of occurrence and distribution of different serotypes, antimicrobial susceptibility profiles, and molecular typing. Science 2008, 39:155-161.
19. Lu Q, Rouby JJ, Laterre PF, Eggimann P, Dugard A, Giamarellos-Bourboulis EJ, Mercier E, Garbino J, Luyt CE, Chastre J, Georgescu-Kyburz V, Rudolf MP, Gafner V, Lazar H, Koch H, Perez A, Kramer SD, Tamm M. Pharmacokinetics and safety of panobacumab: specific adjunctive immunotherapy in critical patients with nosocomial Pseudomonas aeruginosa O11 pneumonia. J Antimicrob Chemother 2011, 66:1110-1116. 10.1093/jac/dkr046, 21398296.
20. American Thoracic Society, Infectious Diseases Society of America Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005, 171:388-416. American Thoracic Society, Infectious Diseases Society of America.
21. Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002, 165:867-903. 10.1164/ajrccm.165.7.2105078, 11934711.
22. Rouby JJ, Martin De Lassale E, Poete P, Nicolas MH, Bodin L, Jarlier V, Le Charpentier Y, Grosset J, Viars P. Nosocomial bronchopneumonia in the critically ill. Histologic and bacteriologic aspects. Am Rev Respir Dis 1992, 146:1059-1066. 10.1164/ajrccm/146.4.1059, 1416397.
23. Pugin J, Auckenthaler R, Mili N, Janssens JP, Lew PD, Suter PM. Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic "blind" bronchoalveolar lavage fluid. Am Rev Respir Dis 1991, 143:1121-1129. 10.1164/ajrccm/143.5_Pt_1.1121, 2024824.
24. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985, 13:818-829. 10.1097/00003246-198510000-00009, 3928249.
25. Bert F, Bruneau B, Lambert-Zechovsky N, Branger C. Epidemiological studies of the susceptibility of Pseudomonas aeruginosa to antibiotics. Pathol Biol (Paris) 1994, 42:491-497.
26. Fonseca AP, Correia P, Sousa JC, Tenreiro R. Association patterns of Pseudomonas aeruginosa clinical isolates as revealed by virulence traits, antibiotic resistance, serotype and genotype. FEMS Immunol Med Microbiol 2007, 51:505-516. 10.1111/j.1574-695X.2007.00328.x, 17877730.
27. Nedeljkovic NS, Kocic B, Tiodorovic B, Brankovic S, Antic SM. Serotyping and analysis of produced pigments kinds by Pseudomonas aeruginosa clinical isolates. Vojnosanit Pregl 2011, 68:923-929. 10.2298/VSP1111923S, 22191308.
28. Nogueira JA. Pseudomonas aeruginosa - agente nosocomial 1995, Porto: Universidade do Porto, In Faculdade de Medicina.
29. Orsi N, Mansi A, Orsi GB, Tomao P, Foresti E, Visca P. Epidemiological characterization of human and environmental Pseudomonas aeruginosa strains: use of plasmid pattern analysis in addition to other typing methods. Ann Ig 1994, 6:653-664.
30. Vachee A, Scheftel JM, Husson MO, Izard D, Ross P, Monteil H. Tricentric study of the sensitivity of Pseudomonas aeruginosa serotyping to beta-lactams and aminoglycosides. Pathol Biol (Paris) 1997, 45:357-362.
31. Pawar M, Mehta Y, Khurana P, Chaudhary A, Kulkarni V, Trehan N. Ventilator-associated pneumonia: incidence, risk factors, outcome, and microbiology. J Cardiothorac Vasc Anesth 2003, 17:22-28. 10.1053/jcan.2003.4, 12635056.
32. Planquette B, Timsit JF, Misset B, Schwebel C, Azoulay E, Adrie C, Vesin A, Jamali S, Zahar JR, Allaouchiche B, Souweine B, Darmon M, Dumenil AS, Goldgran-Toledano D, Mourvillier B, Bedos JP. Pseudomonas Aeruginosa ventilator-associated pneumonia: predictive factors of treatment failure. Am J Respir Crit Care Med 2013, 188:69-76. 10.1164/rccm.201210-1897OC, 23641973.
33. Blot S, Koulenti D, Dimopoulos G, Martin C, Komnos A, Krueger WA, Spina G, Armaganidis A, Rello J. Prevalence, risk factors, and mortality for ventilator-associated pneumonia in middle-aged, old, and very old critically Ill patients. Crit Care Med 2013, Epub ahead of print.
34. Augustin DK, Song Y, Baek MS, Sawa Y, Singh G, Taylor B, Rubio-Mills A, Flanagan JL, Wiener-Kronish JP, Lynch SV. Presence or absence of lipopolysaccharide O antigens affects type III secretion by Pseudomonas aeruginosa. J Bacteriol 2007, 189:2203-2209. 10.1128/JB.01839-06, 1899375, 17209027.
35. Finck-Barbancon V, Goranson J, Zhu L, Sawa T, Wiener-Kronish JP, Fleiszig SM, Wu C, Mende-Mueller L, Frank DW. ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury. Mol Microbiol 1997, 25:547-557. 10.1046/j.1365-2958.1997.4891851.x, 9302017.
36. Kurahashi K, Kajikawa O, Sawa T, Ohara M, Gropper MA, Frank DW, Martin TR, Wiener-Kronish JP. Pathogenesis of septic shock in Pseudomonas aeruginosa pneumonia. J Clin Invest 1999, 104:743-750. 10.1172/JCI7124, 408437, 10491409.
37. Nicas TI, Iglewski BH. Contribution of exoenzyme S to the virulence of Pseudomonas aeruginosa. Antibiot Chemother 1985, 36:40-48.
38. El Solh AA, Akinnusi ME, Wiener-Kronish JP, Lynch SV, Pineda LA, Szarpa K. Persistent infection with Pseudomonas aeruginosa in ventilator-associated pneumonia. Am J Respir Crit Care Med 2008, 178:513-519. 10.1164/rccm.200802-239OC, 2542430, 18467510.
39. Hauser AR, Cobb E, Bodi M, Mariscal D, Valles J, Engel JN, Rello J. Type III protein secretion is associated with poor clinical outcomes in patients with ventilator-associated pneumonia caused by Pseudomonas aeruginosa. Crit Care Med 2002, 30:521-528. 10.1097/00003246-200203000-00005, 11990909.
40. Lisboa T, Waterer G, Rello J. We should be measuring genomic bacterial load and virulence factors. Crit Care Med 2010, 38:S656-S662.